Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2009 Jan 6;15(9):556–562. [Article in Spanish] doi: 10.1016/S1134-2072(08)75292-7

El dengue

Lluís Valerio a, M Dolors Tenas a, Sílvia Roure b
PMCID: PMC7144501  PMID: 32288495

The content is available as a PDF (217.4 KB).

Bibliografía

  • 1.Gubler D.J. The global emergente/resurgence of arboviral diseases as public health problems. Arch Med Res. 2002;33:330–342. doi: 10.1016/s0188-4409(02)00378-8. [DOI] [PubMed] [Google Scholar]
  • 2.López-Vélez R., Molina Moreno R. Climate change in Spain and risk of infectious and parasitic diseases transmitted by arthropods and rodents. Rev Esp Salud Publica. 2005;79:177–190. doi: 10.1590/s1135-57272005000200006. [DOI] [PubMed] [Google Scholar]
  • 3.Sánchez-Seco M.P., Navarro J.M. Infections due to Toscana virus, West Nile virus and other arboviruses of interest in Europe. Enferm Infect Microbiol Clin. 2005;23:560–568. doi: 10.1157/13080267. [DOI] [PubMed] [Google Scholar]
  • 4.Wang E., Ni H., Xu R. Evolutionary relationships of endemic/epidemia and sylvatic dengue virases. J Virol. 2000;74:3227–3234. doi: 10.1128/jvi.74.7.3227-3234.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gubler D.J. Epidemic dengue/dengue hemorragic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 2002;10:100–103. doi: 10.1016/s0966-842x(01)02288-0. [DOI] [PubMed] [Google Scholar]
  • 6.Peterson A.T., Bauer J.T., Mills J.N. Ecologic and geographic distribution of filovirus disease. Emerg Infect Dis. 2004;10:40–47. doi: 10.3201/eid1001.030125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Giménez N., Barahona M., Casasa A., Domingo A., Gavagnach M., Martí C. Llegada de Aedes albopictus en España: un nuevo reto para la salud pública. Gac Sanit. 2007;21:25–28. doi: 10.1157/13099117. [DOI] [PubMed] [Google Scholar]
  • 8.Cox J., Grillet M.E., Ramos O.M., Amador M., Barrera R. Habitat segregation of dengue vectors along an urban environmental gradient. Am J Trop Med Hyg. 2007;76:820–826. [PubMed] [Google Scholar]
  • 9.Halstead S.B. Dengue. Lancet. 2007;370:1644–1652. doi: 10.1016/S0140-6736(07)61687-0. [DOI] [PubMed] [Google Scholar]
  • 10.Fink J., Gu F., Vasidean S.G. Role of T cells, cytokines and antibody in dengue fever and dengue hemorragia fever. Rev Med Virol. 2006;16:263–275. doi: 10.1002/rmv.507. [DOI] [PubMed] [Google Scholar]
  • 11.Green S., Rothman A. Immunopathological mechanisms in dengue and dengue hemorragia fever. Curr Opin Infect Dis. 2006;19:429–436. doi: 10.1097/01.qco.0000244047.31135.fa. [DOI] [PubMed] [Google Scholar]
  • 12.Gascón J., Giner V., Vidal J., Jou J.M., Mas E., Corachan M. Dengue: una enfermedad re-emergente. Estudio clinicoepidemiológico en 57 viajeros españoles. Med Clin (Barc) 1998;111:583–586. [PubMed] [Google Scholar]
  • 13.Wilder-Smith A, Schwartz E. Dengue in travellers. N Engl J Med. 335;9:924-31. [DOI] [PubMed]
  • 14.Seet M.C., Queck A.M., Lim E.C. Post-infectious fatigue syndrome in dengue infection. J Clin Virol. 2007;24:1–6. doi: 10.1016/j.jcv.2006.10.011. [DOI] [PubMed] [Google Scholar]
  • 15.Domingo-Carrasco C., Gascón-Brustenga J. Dengue y otras fiebres hemorrágicas virales. Enferm Infecc Microbiol Clin. 2005;23:615–626. doi: 10.1016/s0213-005x(05)75042-4. [DOI] [PubMed] [Google Scholar]
  • 16.Wichmann O., Gascón J., Schunk M., Puente S., Siikamani H., Gjorup I. Severe dengue virus infection in travelers: risk factors and laboratory indicators. J Infect Dis. 2007;195:1089–1096. doi: 10.1086/512680. [DOI] [PubMed] [Google Scholar]
  • 17.Díaz-Quijano F.A., Martínez-Vega R.A., Villar-Centeno L.A. Indicadores tempranos de gravedad en el dengue. Enferm Infecc Microbiol Clin. 2005;23:529–532. doi: 10.1157/13080262. [DOI] [PubMed] [Google Scholar]
  • 18.Rigau-Pérez J. Severe dengue: the need for new case definitions. Lancet Infect Dis. 2006;6:297–302. doi: 10.1016/S1473-3099(06)70465-0. [DOI] [PubMed] [Google Scholar]
  • 19.Valerio L., De Balanzó X., Jiménez O., Pedro-Botet M.L. Exantema hemorrágico por virus dengue inducido por ácido acetilsalicílico. An Sist Sanit Navar. 2006;29:439–442. doi: 10.4321/s1137-66272006000500012. [DOI] [PubMed] [Google Scholar]
  • 20.Krishnamurti C., Kalayanarooj S., Cutting M.A., Peat R.A., Rothwell S.W., Reid T.J. Mechanisms of hemorrhage in dengue without circulatory collapse. Am J Trop Hyg. 2001;65:840–847. doi: 10.4269/ajtmh.2001.65.840. [DOI] [PubMed] [Google Scholar]
  • 21.Lee I.K., Liu J.W., Yang K.D. Clinical characteristics and risk factors for concurrent bacteremia in adults with dengue hemorrhagic fever. Am J Trop Med Hyg. 2005;72:221–226. [PubMed] [Google Scholar]
  • 22.Domingo-Carrasco C., Gascón-Brustenga Dengue y otras fiebres hemorrágicas virales. Enferm Infecc Micrbiol Clin. 2005;23:615–626. doi: 10.1016/s0213-005x(05)75042-4. [DOI] [PubMed] [Google Scholar]
  • 23.Instituto de Salud Carlos III. Centro Nacional de Microbilogía. Disponible en: http://www.isciii.es/htdocs/centros/microbiologia/microbiologia_presentacion.jsp
  • 24.Blacksell S.D., Newton P.N., Bell D., Kelley J., Mammen R.P., Jr, Gibbons R.V. The comparative accuracy of 8 commercial rapid immunochromatographic assays for the diagnosis of acute dengue virus infection. Clin Infect Dis. 2006;42:1127–1134. doi: 10.1086/501358. [DOI] [PubMed] [Google Scholar]
  • 25.Gubler D.J. Dengue and dengue hemorhragic fever. Clin Microbiol Rev. 1998;11:480–496. doi: 10.1128/cmr.11.3.480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Colbert J.A., Gordon A., Roxelin R. Ultrasound measurement of gallbladder wall thickening as diagnostic test and prognostic indicator for severe dengue in pediatric patients. Pediatr Infect Dis J. 2007;26:850–852. doi: 10.1097/INF.0b013e3180619692. [DOI] [PubMed] [Google Scholar]
  • 27.Muñoz J., Puente S., López-Vélez R., Domingo C., Ruiz J., Ramírez G. Estudio clinicoepidemiológico del dengue importado en España. Med Clin (Barc) 2008;131:18–21. doi: 10.1157/13123037. [DOI] [PubMed] [Google Scholar]
  • 28.Kalayanarooj S., Vaughn D.W., Nimmannitaya S., Green S., Suntayakorn S., Rothman A.L. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis. 1997;176:313–321. doi: 10.1086/514047. [DOI] [PubMed] [Google Scholar]
  • 29.Wills B.A., Dung N.M., Loan H.T. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med. 2005;353:877–889. doi: 10.1056/NEJMoa044057. [DOI] [PubMed] [Google Scholar]
  • 30.Wills B.A., Oragui E.E., Stephens A.C., Daramola O.A., Dung N.M., Loan H.T. Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin Infect Dis. 2002;35:277–285. doi: 10.1086/341410. [DOI] [PubMed] [Google Scholar]
  • 31.Crance J.M., Scaramozzino M., Jouan A., Carin D. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res. 2003;58:73–79. doi: 10.1016/s0166-3542(02)00185-7. [DOI] [PubMed] [Google Scholar]
  • 32.Panpanich R., Somchai P., Kanjanaratanakom K. Corticosteroids for treating dengue shock syndrome. Cochrane Database Syst Rev. 2006;3 doi: 10.1002/14651858.CD003488.pub2. CD003488. [DOI] [PubMed] [Google Scholar]
  • 33.Edelman R. Dengue vaccines approach the finish line. Clin Infect Dis. 2007;45:56–60. doi: 10.1086/518148. [DOI] [PubMed] [Google Scholar]
  • 34.Morrison A.C., Zielinski-Gutiérrez E., Scott T.W., Rosenberg R. Defining challenges and proposing solutions for control of the virus vector Aedes aegypti. PLoS Med. 2008;5:68E. doi: 10.1371/journal.pmed.0050068. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Fmc are provided here courtesy of Elsevier

RESOURCES